Skip to main content
Fig. 3 | Alzheimer's Research & Therapy

Fig. 3

From: Treatment of Alzheimer's Disease subjects with expanded non-genetically modified autologous natural killer cells (SNK01): a phase I study

Fig. 3

Level of interleukin 10 (IL-10) and TGF-β1 in conditioned media (CM) of SNK01 cells. The production of IL-10 (A) and TGF-β1 (B) by SNK01 cells for 2 days cultivation after stimulation with or without K562 target cells for 3 h before harvest at a 1:1 E:T ratio was investigated by ELISA. CM and Activated CM indicate culture supernatant of SNK01 cells treated without (CM) or with target cells (Activated CM)

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193